Core Scientific, Inc.
CORZ
$16.42
-$0.55-3.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 89.81M | 67.24M | 70.79M | 84.95M | 101.93M |
| Total Other Revenue | 229.21M | 266.94M | 277.64M | 325.96M | 408.74M |
| Total Revenue | 319.02M | 334.18M | 348.43M | 410.91M | 510.67M |
| Cost of Revenue | 265.64M | 300.05M | 318.36M | 347.04M | 377.37M |
| Gross Profit | 53.38M | 34.14M | 30.07M | 63.87M | 133.30M |
| SG&A Expenses | 198.08M | 202.99M | 179.49M | 153.93M | 130.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 31.60M | -26.50M | -15.34M | 15.04M | 3.81M |
| Total Operating Expenses | 495.32M | 476.53M | 482.51M | 516.01M | 511.92M |
| Operating Income | -176.30M | -142.35M | -134.08M | -105.11M | -1.25M |
| Income Before Tax | -288.03M | -890.31M | -1.20B | -1.07B | -1.44B |
| Income Tax Expenses | 583.00K | 863.00K | 872.00K | 858.00K | 859.00K |
| Earnings from Continuing Operations | -288.62 | -891.18 | -1.20K | -1.07K | -1.44K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -288.62M | -891.18M | -1.20B | -1.07B | -1.44B |
| EBIT | -176.30M | -142.35M | -134.08M | -105.11M | -1.25M |
| EBITDA | -107.39M | -61.49M | -40.86M | -1.17M | 111.95M |
| EPS Basic | -0.89 | -2.48 | -3.19 | -6.86 | -5.78 |
| Normalized Basic EPS | -0.40 | -1.43 | -2.16 | -3.15 | -4.03 |
| EPS Diluted | -1.07 | -2.49 | -3.20 | -6.86 | -5.91 |
| Normalized Diluted EPS | -0.56 | -1.43 | -2.16 | -3.15 | -4.08 |
| Average Basic Shares Outstanding | 1.27B | 1.26B | 1.23B | 1.09B | 1.01B |
| Average Diluted Shares Outstanding | 1.42B | 1.26B | 1.23B | 1.09B | 1.06B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |